Victim, suspect identified in deadly downtown stabbing
Published Fri, 21 Feb 2025 18:19:58 GMT
John Lennon's art collection unveiled in San Diego for first time in a decade
Published Fri, 21 Feb 2025 18:19:58 GMT
Alberta doctors ‘trepidatious’ about changes to already fragile health-care system
Published Fri, 21 Feb 2025 18:19:58 GMT
Coalition of Canadian doctors urge for immediate ceasefire in Gaza
Published Fri, 21 Feb 2025 18:19:58 GMT
Maine mass shooting puts spotlight on complex array of laws, series of massive failures
Published Fri, 21 Feb 2025 18:19:58 GMT
Report finds no evidence of mechanical failure in plane crash that killed North Dakota lawmaker
Published Fri, 21 Feb 2025 18:19:58 GMT
A New York City lawmaker has been charged with bringing a gun to a pro-Palestinian protest
Published Fri, 21 Feb 2025 18:19:58 GMT
Justice Department opens civil rights probes into South Carolina jails beset by deaths and violence
Published Fri, 21 Feb 2025 18:19:58 GMT
US Air Force terminates missile test flight due to anomaly after California launch
Published Fri, 21 Feb 2025 18:19:58 GMT
Rwanda announces visa-free travel for all Africans as continent opens up to free movement of people
Published Fri, 21 Feb 2025 18:19:58 GMT
Latest news
- RPM International, Acuity Brands rise; Cal-Maine, Helen of Troy fall, Wednesday, 10/4/2023
- Kenyan opposition lawmakers say the Haiti peacekeeping mission must be approved by parliament
- Tennis player apologizes for hitting a chair umpire with ball in Shanghai Masters qualifying
- Jannik Sinner wins China Open. Iga Swiatek advances to quarterfinals
- Pakistani army says 2 people were killed when a Taliban guard opened fire at a border crossing
- Meet this year’s MacArthur ‘genius grant’ recipients, including a hula master and the poet laureate
- A man charged with voter fraud in Florida blames rivalry between Trump and DeSantis supporters
- Rudy Giuliani: ‘I have never had an alcohol problem’
- Scalise and Jordan launch bids for House speaker after McCarthy ouster
- Moderna’s flu-Covid combo vaccine elicits ‘strong’ immune response in Phase 1/2 study, company says